SCHEMBL5846723

SCHEMBL5846723

O=C1CCCCc2c1ccc(Cl)c2Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.39
MAOA P21397 3/20 0.39
MAOB P27338 3/20 0.39
PRKCI P41743 1/20 0.39
NOTUM Q6P988 3/20 0.39
BRD4 O60885 3/20 0.38
BRD9 Q9H8M2 3/20 0.38
BRDT Q58F21 2/20 0.38
BRD7 Q9NPI1 2/20 0.38
CREBBP Q92793 1/20 0.38
CECR2 Q9BXF3 1/20 0.38
PNMT P11086 3/20 0.37
CES1 P23141 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
CYP2A6 P11509 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31170780 0.96 MAOA (0.43) PARP1MAOAMAOBPRKCINOTUM
SCHEMBL1695315 0.96 MAOA (0.43) PARP1MAOAMAOBPRKCINOTUM
SCHEMBL8557216 0.88 NOTUM (0.44) MAOAMAOBPRKCINOTUMPNMT
SCHEMBL24362691 0.81 MAOA (0.44) MAOAMAOBPRKCIBRD4CYP2A6
SCHEMBL13093582 0.78 MAOA (0.42) MAOAMAOBPRKCIBRD4CYP2A6
SCHEMBL10753610 0.77 MEN1 (0.46) PARP1MAOAMAOBPRKCIBRD4
SCHEMBL22253606 0.77 MAOA (0.41) PARP1MAOAMAOBPRKCIBRD4
SCHEMBL31620328 0.77 MAOA (0.41) PARP1MAOAMAOBPRKCIBRD4
SCHEMBL24542979 0.77 NOTUM (0.41) PARP1MAOAMAOBPRKCINOTUM
SCHEMBL31156850 0.77 MAOA (0.49) MAOAMAOBPRKCIBRD4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034051-B2 Fused bicyclic carboxamide derivatives and methods of their use ADOLOR CORPORATION (US) 2006-04-25 US disclosed
WO-2005023799-A1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2005-03-17 WO disclosed
US-20050054630-A1 Fused bicyclic carboxamide derivatives and methods of their use CUBIST PHARMACEUTICALS, INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054630-A1 Fused bicyclic carboxamide derivatives and methods of their use PAICS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CPS1 PARP1 666/4885MAOA 312/4885MAOB 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.